Economic consequences of chronic obstructive pulmonary disease

Area of Science:

• Public Health
• Health Economics

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global cause of illness and death.
• The economic impact of COPD on society remains largely unquantified.
• Existing data on COPD's economic burden is limited.

Purpose of the Study:

• To review the medical and economic literature on COPD.
• To provide insights into the societal economic burden of COPD.
• To inform clinicians and policymakers on resource allocation for COPD.

Main Methods:

• Literature review of medical and economic studies on COPD.
• Analysis of existing estimates of COPD's burden of illness.
• Examination of healthcare expenditures for individuals with COPD.

Main Results:

• Only two published estimates quantify the overall burden of COPD.
• In 1970, the estimated societal burden of emphysema was $1.5 billion.
• Individuals with COPD incur healthcare costs more than double those without the condition.

Conclusions:

• The economic burden of COPD is substantial and projected to increase significantly.
• COPD presents a significant and ongoing public health challenge.
• Further research is needed to fully understand and address the economic impact of COPD.